{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:31:12Z","timestamp":1791117072088,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.blre.2004.03.002","type":"journal-article","created":{"date-parts":[[2004,6,15]],"date-time":"2004-06-15T19:32:24Z","timestamp":1087327944000},"page":"39-51","source":"Crossref","is-referenced-by-count":70,"title":["Splenic marginal zone lymphoma"],"prefix":"10.1016","volume":"19","author":[{"given":"David","family":"Oscier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2004.03.002_BIB1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1996.d01-1711.x","article-title":"Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC)","volume":"93","author":"Troussard","year":"1996","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/jcp.40.6.642","article-title":"Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens","volume":"40","author":"Melo","year":"1987","journal-title":"J. Clin. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jcp.42.6.567","article-title":"Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group","volume":"42","author":"Bennett","year":"1989","journal-title":"J. Clin. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-199205000-00004","article-title":"Splenic marginal zone cell lymphoma","volume":"16","author":"Schmid","year":"1992","journal-title":"Am. J. Surg. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB5","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V84.11.3828.bloodjournal84113828","article-title":"The histopathology of splenic lymphoma with villous lymphocytes","volume":"84","author":"Isaacson","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB7","series-title":"Pathology and Genetics of Tumours of Haematopoetic and Lymphoid Tumours","first-page":"135","article-title":"Splenic marginal zone lymphoma","author":"Isaacson","year":"2001"},{"key":"10.1016\/j.blre.2004.03.002_BIB8","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.blre.2004.03.002_BIB9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","article-title":"Splenic marginal-zone lymphoma: a distinct clinical and pathological entity","volume":"4","author":"Thieblemont","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.blre.2004.03.002_BIB10","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1182\/blood-2002-07-2216","article-title":"Splenic marginal zone lymphoma","volume":"101","author":"Franco","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB11","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients","volume":"100","author":"Chacon","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2141.2003.04165.x","article-title":"Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients","volume":"120","author":"Parry-Jones","year":"2003","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB13","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1096-8652(199711)56:3<173::AID-AJH7>3.0.CO;2-V","article-title":"Immunological abnormalities in splenic marginal zone cell lymphoma","volume":"56","author":"Murakami","year":"1997","journal-title":"Am. J. Hematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01737426","article-title":"Multiple autoantibody production in a patient with splenic lymphoma","volume":"68","author":"Sawamura","year":"1994","journal-title":"Ann. Hematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB16","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/0140-6736(92)93135-A","article-title":"Splenic lymphoma with villous lymphocytes complicated by autoimmune haemolytic anaemia","volume":"340","author":"Gale","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2004.03.002_BIB17","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1046\/j.1365-2141.1997.d01-2088.x","article-title":"Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells","volume":"96","author":"Tefferi","year":"1997","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/jcp.55.10.789","article-title":"Spontaneous regression of acquired C1 esterase inhibitor deficiency associated with splenic marginal zone lymphoma presenting with recurrent angio-oedema","volume":"55","author":"Phanish","year":"2002","journal-title":"J. Clin. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","article-title":"Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients","volume":"3","author":"Thieblemont","year":"2002","journal-title":"Clin. Lymphoma"},{"key":"10.1016\/j.blre.2004.03.002_BIB20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1200\/JCO.2002.20.1.342","article-title":"Extramedullary sites of involvement in hematologic malignancies: case 2. Lymphocyte morphology in splenic marginal zone lymphoma","volume":"20","author":"Owen","year":"2002","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.blre.2004.03.002_BIB21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-2141.2003.04449.x","article-title":"Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes","volume":"122","author":"Audouin","year":"2003","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB22","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000478-199510000-00005","article-title":"Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases","volume":"19","author":"Mollejo","year":"1995","journal-title":"Am. J. Surg. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2559.2002.01314.x","article-title":"Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?","volume":"40","author":"Mollejo","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.blre.2004.03.002_BIB24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00000478-199707000-00005","article-title":"Lymph node involvement by splenic marginal zone lymphoma: morphological and immunohistochemical features","volume":"21","author":"Mollejo","year":"1997","journal-title":"Am. J. Surg. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB25","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","article-title":"Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases","volume":"25","author":"Camacho","year":"2001","journal-title":"Am. J. Surg. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0046-8177(99)90031-X","article-title":"Splenic marginal zone lymphoma with increased number of blasts: an aggressive variant?","volume":"30","author":"Lloret","year":"1999","journal-title":"Hum. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB27","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1182\/blood.V83.6.1558.1558","article-title":"The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders","volume":"83","author":"Matutes","year":"1994","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.blre.2004.03.002_BIB28","first-page":"57","article-title":"The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes","volume":"14","author":"Matutes","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2004.03.002_BIB29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2141.1993.tb03337.x","article-title":"Cytogenetic studies in splenic lymphoma with villous lymphocytes","volume":"85","author":"Oscier","year":"1993","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB30","first-page":"71","article-title":"Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q","volume":"86","author":"Sole","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2004.03.002_BIB31","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0002-9440(10)64140-5","article-title":"Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics","volume":"158","author":"Hernandez","year":"2001","journal-title":"Am. J. Pathol"},{"issue":"7","key":"10.1016\/j.blre.2004.03.002_BIB32","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2003-06-2160","article-title":"Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis","volume":"103","author":"Thieblemont","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0165-4608(96)00025-8","article-title":"Structural abnormalities of chromosome 7q in chronic lymphoproliferative disorders","volume":"92","author":"Oscier","year":"1996","journal-title":"Cancer Genet. Cytogenet"},{"key":"10.1016\/j.blre.2004.03.002_BIB34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/gcc.10142","article-title":"Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes","volume":"36","author":"Gruszka-Westwood","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2004.03.002_BIB35","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)65411-9","article-title":"7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma","volume":"154","author":"Mateo","year":"1999","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB36","first-page":"286b","article-title":"Splenic marginal zone lymphoma and splenic lymphoma with villous lymphocytes: a single disease entity [abstract]","volume":"100","author":"Oscier","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1098-2264(199702)18:2<147::AID-GCC10>3.0.CO;2-H","article-title":"Molecular delineation of the commonly deleted segment in mature B-cell lymphoid neoplasias with deletion of 7q","volume":"18","author":"Hernandez","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2004.03.002_BIB38","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2141.1999.01209.x","article-title":"The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH","volume":"104","author":"Gruszka-Westwood","year":"1999","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB39","first-page":"31","article-title":"Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma","volume":"88","author":"Gazzo","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2004.03.002_BIB40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/1042819021000055129","article-title":"Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma","volume":"44","author":"Martinez-Climent","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2004.03.002_BIB41","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.leu.2402191","article-title":"A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma","volume":"15","author":"Cuneo","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2004.03.002_BIB42","first-page":"357","article-title":"Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia","volume":"87","author":"Brito-Babapulle","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2004.03.002_BIB43","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1038\/sj.onc.1203033","article-title":"Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations","volume":"18","author":"Corcoran","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2004.03.002_BIB44","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood.V98.9.2837","article-title":"Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies","volume":"98","author":"Sonoki","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB45","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood.V83.12.3664.3664","article-title":"Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene","volume":"83","author":"Jadayel","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB46","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1182\/blood-2002-10-3236","article-title":"MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma","volume":"101","author":"Sanchez-Izquierdo","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB47","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood.V84.1.270.270","article-title":"Frequent p53 gene involvement in splenic B-cell leukemia\/lymphomas of possible marginal zone origin","volume":"84","author":"Baldini","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB48","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/blood.V97.11.3552","article-title":"p53 abnormalities in splenic lymphoma with villous lymphocytes","volume":"97","author":"Gruszka-Westwood","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB49","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9440(10)63862-X","article-title":"Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations","volume":"162","author":"Tierens","year":"2003","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB50","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood.V99.4.1299","article-title":"Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course","volume":"99","author":"Algara","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB51","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2002-01-0169","article-title":"V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo","volume":"100","author":"Zhu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB52","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V85.6.1603.bloodjournal8561603","article-title":"Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes","volume":"85","author":"Zhu","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2141.1999.01679.x","article-title":"VH gene sequences from a novel tropical splenic lymphoma reveal a naive B cell as the cell of origin","volume":"107","author":"Zhu","year":"1999","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0002-9440(10)64159-4","article-title":"Splenic marginal zone lymphomas appear to originate from different B cell types","volume":"161","author":"Bahler","year":"2002","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood.V93.1.226","article-title":"Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion","volume":"93","author":"Tierens","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB56","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/sj.leu.2400878","article-title":"Chronic malaria and splenic lymphoma: clues to understanding lymphoma evolution","volume":"11","author":"Bates","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2004.03.002_BIB57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.blre.2004.03.002_BIB58","first-page":"601","article-title":"Absence of cyclin D1 protein expression in splenic marginal zone lymphoma","volume":"11","author":"Savilo","year":"1998","journal-title":"Mod. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB59","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<242::AID-AJH8>3.0.CO;2-A","article-title":"Splenic involvement by blastic mantle cell lymphoma (large cell\/anaplastic variant) mimicking splenic marginal zone lymphoma","volume":"62","author":"Mollejo","year":"1999","journal-title":"Am. J. Hematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0046-8177(99)90003-5","article-title":"Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin's Lymphoma Classification Project","volume":"30","author":"Nathwani","year":"1999","journal-title":"Hum. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB61","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1309\/4LCN-JMPG-5U71-UWQB","article-title":"Waldenstrom macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors","volume":"116","author":"Owen","year":"2001","journal-title":"Am. J. Clin. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB62","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0248-8663(98)80393-7","article-title":"[Splenic lymphoma with villous lymphocytes and Waldenstrom disease: diagnostic difficulties by way of a case report]","volume":"19","author":"Seve","year":"1998","journal-title":"Rev. Med. Int"},{"issue":"6","key":"10.1016\/j.blre.2004.03.002_BIB63","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2003-09-3277","article-title":"Monoclonal CD5+ and CD5\u2212 B-lymphocyte expansions are frequent in the peripheral blood of the elderly","volume":"103","author":"Ghia","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB64","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.1997.3973215.x","article-title":"Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutations","volume":"99","author":"Baldini","year":"1997","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB65","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.1991.tb04417.x","article-title":"Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases","volume":"78","author":"Mulligan","year":"1991","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB66","first-page":"1214","article-title":"Ruptured spleens with expanded marginal zones do not reveal occult B-cell clones","volume":"10","author":"Kroft","year":"1997","journal-title":"Mod. Pathol"},{"key":"10.1016\/j.blre.2004.03.002_BIB67","first-page":"148","article-title":"Splenic lymphoma with circulating villous lymphocytes\/splenic marginal-zone lymphoma","volume":"36","author":"Catovsky","year":"1999","journal-title":"Semin. Hematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1526-9655(11)70244-5","article-title":"The role of splenectomy in splenic marginal zone B-cell lymphoma","volume":"3","author":"Marti","year":"2002","journal-title":"Clin. Lymphoma"},{"key":"10.1016\/j.blre.2004.03.002_BIB69","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7861\/clinmedicine.2-5-440","article-title":"Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen","volume":"2","author":"Davies","year":"2002","journal-title":"Clin. Med"},{"key":"10.1016\/j.blre.2004.03.002_BIB70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0142(20010115)91:2<294::AID-CNCR1001>3.0.CO;2-W","article-title":"Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes","volume":"91","author":"Franco","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2004.03.002_BIB71","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1046\/j.1365-2141.1998.1161f.x","article-title":"Low and medium dose spleen radiation therapy are able to induce long-term responses in splenic lymphoma with villous lymphocytes","volume":"103","author":"El Weshi","year":"1998","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2141.1997.3523168.x","article-title":"Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes","volume":"99","author":"Bolam","year":"1997","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB73","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.leu.2401710","article-title":"Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes","volume":"14","author":"Lefrere","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2004.03.002_BIB74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-0609.2002.02759.x","article-title":"Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes","volume":"69","author":"Yasukawa","year":"2002","journal-title":"Eur. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1365-2141.1998.0636f.x","article-title":"Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA)","volume":"100","author":"Virchis","year":"1998","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.blre.2004.03.002_BIB76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10428190009054887","article-title":"Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes","volume":"40","author":"Lefrere","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2004.03.002_BIB77","first-page":"132a","article-title":"Pentostatin in the treatment of splenic lymphoma with villous lymphocytes. A phase II study. Preliminary results [abstract]","volume":"98","author":"Iannitto","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB78","first-page":"160a","article-title":"Splenic marginal zone lymphoma with or without villous lymphocytes. Hematological findings in a series of 57 patients [abstract]","volume":"100","author":"Iannitto","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB79","first-page":"134a","article-title":"Treatment of splenic lymphoma with villous lymphocytes (SLVL) and marginal zone lymphoma (MZL) with single agent Rituximab [abstract]","volume":"98","author":"Thomas","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2004.03.002_BIB80","first-page":"312b","article-title":"Rituximab is effective for patients with splenic lymphoma with villous lymphocytes [abstract]","volume":"100","author":"Daniels","year":"2002","journal-title":"Blood"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X04000177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X04000177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T12:24:17Z","timestamp":1585830257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X04000177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0268960X04000177"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2004.03.002","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}